Conor Richardson

Chief Financial Officer at Kayak Therapeutics.

Earliest Form D on file: May 2026

Filed May 27, 2026

Kayak Therapeutics

TRIM7 inhibitors for RAS-driven solid tumors

Biotech, Austin TX

Signed as Chief Financial Officer

$11.94M

sold of $25M offered

Network

At Kayak Therapeutics

3 people

Josiah Hornblower
Executive Officer, Director
Taylor Schreiber
Director
Tyler Brous
Director